
Senti Biosciences rose 58.5% from $1.76 to a 1-year high of $2.79, ahead of the S&P 500's +8.0%. Its worst day was Jul 15 (−39.7%), and its low came Nov 18 at $0.09.
Nov 19, 2025 – Nov 19, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.53 missed the $-0.46 estimate on $22,000.00 revenue (est. $500,000.00).
−10.4% · S&P 500 −1.7%
Story events cover the past 12 months · Times ET
EPS of $-0.14 beat the $-0.34 estimate on $16,000.00 revenue.
+8.0% · S&P 500 +0.8%
EPS of $-0.41 missed the $-0.28 estimate on $17,000.00 revenue.
−4.2% · S&P 500 −0.5%
EPS of $-0.37 missed the $-0.31 estimate on $19,000.00 revenue.
−28.7% · S&P 500 −1.0%
Where it ended: a 1-year high close of $2.79 on Nov 19, 2026.
Nothing in the past 12 months.
All SNTI dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SNTI and SPY from Benzinga historical bars. Not investment advice.